![Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political](https://indiastatestimes.in/wp-content/uploads/2021/04/2021_4largeimg26_Apr_2021_163233727.jpg)
Glenmark's Ryaltris nasal spray now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age | News Headlines, Latest News , Business and Political
![Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier](https://www.drugs.com/images/pills/custom/pill34249-1/ryaltris.png)
Ryaltris olopatadine hydrochloride 665 mcg / mometasone furoate 25 mcg per 0.1 mL nasal spray Images - Pill Identifier
![RYALTRIS™ - Nasal Spray | RYALTRIS™ is a 2-in-1 nasal spray that starts to deliver multitasking relief of symptoms within 15 minutes RYALTRIS™ - Nasal Spray | RYALTRIS™ is a 2-in-1 nasal spray that starts to deliver multitasking relief of symptoms within 15 minutes](https://us.ryaltris.com/wp-content/uploads/2022/12/mi_bottle_rr15_v8-944x1024.png)
RYALTRIS™ - Nasal Spray | RYALTRIS™ is a 2-in-1 nasal spray that starts to deliver multitasking relief of symptoms within 15 minutes
![Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA | Healthcare Packaging Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA | Healthcare Packaging](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2022/02/Image_1.620e8e1c6cb5c.png?auto=format%2Ccompress&q=70&w=400)